Skip to main content

Incidence of Moyamoya Disease in Denmark: A Population-Based Register Study

  • Conference paper
  • First Online:
Book cover Trends in the Management of Cerebrovascular Diseases

Part of the book series: Acta Neurochirurgica Supplement ((NEUROCHIRURGICA,volume 129))

Abstract

In this first population-based study of moyamoya disease (MMD) in Europe, the authors identified 56 patients with MMD in Denmark during the period 1994–2015 using nationwide registers. The overall incidence was 0.047 per 100,000 person-years, which is about one-tenth that reported in Japan. Otherwise the epidemiological features were comparable: there was a bimodal age distribution with peaks in the age groups 0–9 years and 30–39 years, with twice as many females as males.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360:1226–37.

    Article  CAS  Google Scholar 

  2. Birkeland P, Gardner K, Kesse-Adu R, Davies J, Lauritsen J, Rom Poulsen F, Tolias CM, Thein SL. Intracranial aneurysms in sickle-cell disease are associated with the hemoglobin SS genotype but not with moyamoya syndrome. Stroke. 2016;47:1710–3.

    Article  Google Scholar 

  3. Hansen RN, Andersen G, Longin E. Moyamoya. Ugeskr Laeger. 2011;173:281–2.

    PubMed  Google Scholar 

  4. Kondziella D. Diagnosis and treatment of rare causes of ischaemic stroke. Ugeskr Laeger. 2016;178:V02160101.

    PubMed  Google Scholar 

  5. Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008;79:900–4.

    Article  CAS  Google Scholar 

  6. Hoshino H, Izawa Y, Suzuki N. Epidemiological features of moyamoya disease in Japan. Neurol Med Chir (Tokyo). 2012;52:295–8.

    Article  Google Scholar 

  7. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, Kojima M, Lin Y, Ohno Y. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg. 1997;99(Suppl 2):S1–5.

    Article  Google Scholar 

  8. Acker G, Goerdes S, Schneider UC, Schmiedek P, Czabanka M, Vajkoczy P. Distinct clinical and radiographic characteristics of moyamoya disease amongst European Caucasians. Eur J Neurol. 2015;22:1012–7.

    Article  CAS  Google Scholar 

  9. Hever P, Alamri A, Tolias C. Moyamoya angiopathy—is there a Western phenotype? Br J Neurosurg. 2015;29:765–71.

    Article  Google Scholar 

  10. Kleinloog R, Regli L, Rinkel GJ, Klijn CJ. Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review. J Neurol Neurosurg Psychiatry. 2012;83:531–6.

    Article  Google Scholar 

  11. Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health. 2011;39:30–3.

    Article  Google Scholar 

  12. Uchino K, Johnston SC, Becker KJ, Tirschwell DL. Moyamoya disease in Washington State and California. Neurology. 2005;65:956–8.

    Article  Google Scholar 

  13. Kossorotoff M, Herve D, Toulgoat F, Renaud C, Presles E, Chabriat H, Chabrier S. Paediatric moyamoya in mainland France: a comprehensive survey of academic neuropaediatric centres. Cerebrovasc Dis. 2012;33:76–9.

    Article  CAS  Google Scholar 

  14. Research Committee on the Pathology and Treatment of Spontaneous. Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measure for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012;52:245–66.

    Article  Google Scholar 

  15. Wermuth L, Lassen CF, Himmerslev L, Olsen J, Ritz B. Validation of hospital register-based diagnosis of Parkinson’s disease. Dan Med J. 2012;59:A4391.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Birkeland M.D. .

Editor information

Editors and Affiliations

Ethics declarations

Ethical Approval

For this type of study formal consent is not required.

Conflict of Interest

The authors declare that they have no conflict of interest.

Funding

This study was supported by a grant from Ingeniør K.A. Rohde of Hustrus Legat.

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Birkeland, P., Lauritsen, J. (2018). Incidence of Moyamoya Disease in Denmark: A Population-Based Register Study. In: Esposito, G., Regli, L., Kaku, Y., Tsukahara, T. (eds) Trends in the Management of Cerebrovascular Diseases. Acta Neurochirurgica Supplement, vol 129. Springer, Cham. https://doi.org/10.1007/978-3-319-73739-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-73739-3_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-73738-6

  • Online ISBN: 978-3-319-73739-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics